发明名称 Use of hypothalmic inhibitory factor in the treatment of ischemic cardiac malfunction
摘要 The present invention is based on the unexpected discoveries that hypothalamic inhibitory factor (HIF) has a positive inotropic effect in a whole organ preparation, such as an isolated perfused heart, and that HIF, to a greater extent than ouabain, dilates the coronary arteries in the isolated perfused heart as manifested in increased coronary flow in hearts treated with HIP. The present invention relates to a method for increasing coronary perfusion in a mammalian host comprising administering to the host in need thereof an effective amount of hypothalamic inhibitory factor (HIF). The invention also relates to a method for producing an increased coronary vasodilatory effect in a mammalian host comprising administering to a mammalian host in need thereof an effective amount of HIF. The method of the present invention can be used to prevent and/or treat ischemic cardiac malfunction and coronary artery restenosis.
申请公布号 AU7603598(A) 申请公布日期 1998.12.30
申请号 AU19980076035 申请日期 1998.05.28
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 GARNER T. HAUPERT JR.
分类号 A61K31/70;A61K31/704;A61P9/10 主分类号 A61K31/70
代理机构 代理人
主权项
地址